Drawing for MEDIDATA INSIGHTS

USPTO serial 85932979

MEDIDATA INSIGHTS

Reviewed by CopyMark Law Group

Reg. 4458837Status 710
Filing date
Status date
Registration date
Dec 31, 2013
Examiner
PRATER, JILL I
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MEDIDATA INSIGHTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A LaVine

JORDAN A LAVINE FLASTER/GREENBERG P.C.1600 JFK BLVD FL 2PHILADELPHIA, PA 19103-2808UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042software as a service (saas) solutions featuring software for use in managing data and information in the field of medical clinical trials and research and for evaluating and benchmarking the performance of clinical trials and medical research; clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research for the purpose of evaluating and benchmarking the performance of clinical trials and medical research; clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely clinical trial design and protocol development, clinical trial planning and management, clinical trial user and learning management, clinical trial operational reporting and analytics, clinical trial randomization and trial supply management, clinical trial monitoring and events capture and clinical data capture, management and reportingSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 7, 2020C8..CANCELLED SEC. 8 (6-YR)—
Dec 31, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 7, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 31, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2013DOCKASSIGNED TO EXAMINER—
May 25, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
May 24, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance